These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11369842)

  • 21. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Law MC; Chow KM; Li PK; Lui SF; Sanderson JE
    Kidney Int; 2002 Aug; 62(2):639-47. PubMed ID: 12110029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular consequences of renal anaemia and erythropoietin therapy.
    Eckardt KU
    Nephrol Dial Transplant; 1999 May; 14(5):1317-23. PubMed ID: 10344393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of early treatment of the anaemia of chronic kidney disease.
    Eknoyan G
    Nephrol Dial Transplant; 2001; 16 Suppl 5():45-9. PubMed ID: 11509684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular hypertrophy: why does it happen?
    London GM
    Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii2-6. PubMed ID: 14607992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure.
    Singh NP; Chandrashekhar ; Nair M; Anuradha S; Kohli R; Agarwal SK
    J Assoc Physicians India; 2000 Mar; 48(3):301-6. PubMed ID: 11229114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The relationship between insulin resistance and left ventricular hypertrophy in patients with early chronic kidney disease.].
    Wang CJ; Bao XR
    Zhonghua Nei Ke Za Zhi; 2009 Dec; 48(12):999-1003. PubMed ID: 20193515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaemia and early phase cardiovascular events on haemodialysis.
    Hayashi T; Joki N; Tanaka Y; Hase H
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():1-6. PubMed ID: 26456311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiovascular disease in pediatric patients under chronic peritoneal dialysis].
    Lehmann F P; Cano Sc F
    Rev Chil Pediatr; 2017 Apr; 88(2):236-242. PubMed ID: 28542658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of anaemia on cardiovascular status.
    O'Riordan E; Foley RN
    Nephrol Dial Transplant; 2000; 15 Suppl 3():19-22. PubMed ID: 11032353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure.
    Tucker B; Fabbian F; Giles M; Johnston A; Baker LR
    Clin Nephrol; 1999 Dec; 52(6):377-82. PubMed ID: 10604646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive outcomes of high hemoglobin target in patients with chronic kidney disease not on dialysis: a randomized controlled study.
    Akizawa T; Gejyo F; Nishi S; Iino Y; Watanabe Y; Suzuki M; Saito A; Akiba T; Hirakata H; Fukuhara S; Morita S; Hiroe M; Hada Y; Suzuki M; Akaishi M; Iwasaki M; Tsubakihara Y;
    Ther Apher Dial; 2011 Oct; 15(5):431-40. PubMed ID: 21974695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaemia in chronic renal disease: lessons learned since Seville 1994.
    Parfrey P
    Nephrol Dial Transplant; 2001; 16 Suppl 7():41-5. PubMed ID: 11590256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemoglobin levels, cardiovascular disease, and left ventricular hypertrophy in patients with chronic kidney disease. Case study of the anemic patient.
    Butler KG
    Nephrol Nurs J; 2002 Apr; 29(2):189-92. PubMed ID: 11997954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaemia: cardiovascular adaptations and maladaptive responses in chronic kidney disease.
    Foley RN
    Nephrol Dial Transplant; 2002; 17 Suppl 11():32-4. PubMed ID: 12386255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of long-term amelioration of anemia and blood pressure control on left ventricular hypertrophy in hemodialyzed patients.
    Zehnder C; Zuber M; Sulzer M; Meyer B; Straumann E; Jenzer HR; Blumberg A
    Nephron; 1992; 61(1):21-5. PubMed ID: 1388250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.